Peginterferon alfa2 a (40 kD) and ribavirin combination therapy in chronic hepatitis C: a randomized study of the effect of treatment duration and ribavirin dose. - Hadziyannis,S.J.; Dunant,H.; Sette,H.J. (Ann Intern Med, 2004)